Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT
Ligand Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 47.63M | 45.33M | 42.81M | 51.81M | 41.53M | 30.98M | 28.1M | 32.87M | 26.37M | 43.98M | 50.38M | 66.09M | 57.42M | 45.69M | 72.47M | 64.83M | 84.67M | 55.15M |
Cost of Revenue | 818.5K | 4.85M | 2.84M | 12.49M | 11.16M | 11.07M | 1.66M | 3.48M | 1.67M | 3.72M | 21.61M | 14.15M | 12.36M | 4.7M | 11.98M | 11.45M | 30.59M | 8.15M |
Gross Profit | 46.81M | 40.48M | 39.98M | 39.32M | 30.37M | 19.91M | 26.44M | 29.38M | 24.7M | 40.26M | 28.77M | 51.94M | 45.06M | 40.99M | 60.49M | 53.39M | 54.08M | 47M |
Operating Income | 8.44M | -36.22M | -9.64M | 3.14M | -19.1M | 2.99M | -3.36M | 3.08M | -1.98M | 14.21M | -20.1M | 1.56M | 1.44M | -6.61M | 9.39M | 15.71M | 45.74M | 4.71M |
Interest Income | 468K | 1.77M | 1.93M | 1.35M | 2.76M | 2.02M | 1.69M | 2.26M | 2.32M | 1.44M | 1.02M | 591K | 298K | 134K | 188K | 169K | 233K | 296K |
Pretax Income | 11.22M | -50.18M | -39.2M | -6.34M | -65.39M | 113.45M | 17.1M | -12.14M | 3.17M | 55.54M | 24.14M | 857K | -636K | -20.14M | -7.03M | 15.26M | 33.3M | 5.76M |
Net Income | 4.85M | -42.45M | -31.09M | -7.17M | -51.91M | 86.14M | 18.19M | -10.27M | 2.29M | 41.95M | -14.53M | 404K | -895K | -15.38M | -4.97M | 13.72M | 30.73M | 18.11M |
Selling & General & Admin | 20.18M | 18.8M | 25.61M | 24.48M | 17.62M | 10.95M | 15.99M | 14.66M | 11.29M | 10.86M | 31.13M | 17.45M | 14.59M | 18.18M | 17.74M | 12.72M | 14.71M | 12.62M |
Research & Development | 6.57M | 50.09M | 4.42M | 5.67M | 5.35M | 5.97M | 5.49M | 5.53M | 6.85M | 6.66M | 9.2M | 22.04M | 19.12M | 20.31M | 18.24M | 16.94M | 15.95M | 17.88M |
Other Expenses | 10.35M | 7.81M | 19.58M | 6.02M | 34.75M | n/a | -8.31M | -4.3M | -873K | 8.54M | 8.54M | 11.82M | 11.82M | 11.81M | 11.78M | 8.03M | -22.32M | 11.79M |
Operating Expenses | 37.09M | 76.7M | 49.61M | 36.17M | 57.73M | 16.92M | 29.8M | 28.43M | 26.68M | 26.06M | 48.87M | 51.3M | 45.53M | 50.3M | 47.76M | 37.68M | 8.34M | 42.28M |
Interest Expense | 867K | 867K | 883K | 741K | 1.27M | 141K | 131K | 1K | 284K | 240K | 240K | 332K | 438K | 789K | 4.47M | 4.44M | 4.88M | 5.83M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.18M | 81.55M | 52.45M | 48.67M | 60.63M | 27.99M | 31.46M | 31.91M | 28.35M | 29.77M | 70.48M | 65.45M | 57.89M | 55M | 59.74M | 49.13M | 38.94M | 50.44M |
Income Tax Expense | 6.38M | -7.73M | -8.11M | 833K | -13.48M | 27.31M | -1.09M | -1.87M | 881K | 11.92M | 38.67M | 453K | 259K | -4.75M | -2.06M | 1.54M | 2.58M | -12.34M |
Shares Outstanding (Basic) | 19.26M | 19.19M | 18.97M | 18.42M | 18.03M | 17.73M | 17.47M | 17.38M | 17.28M | 17.06M | 16.89M | 16.89M | 16.87M | 16.79M | 16.73M | 16.69M | 16.66M | 16.43M |
Shares Outstanding (Diluted) | 19.26M | 19.19M | 18.97M | 18.42M | 18.03M | 18.12M | 17.68M | 17.38M | 17.73M | 17.97M | 16.89M | 17.13M | 16.87M | 16.82M | 16.73M | 17.14M | 17.17M | 17.25M |
EPS (Basic) | 0.25 | -2.21 | -1.64 | -0.39 | -2.88 | 4.86 | 1.04 | -0.74 | 0.13 | 2.46 | -0.86 | 0.02 | -0.05 | -0.92 | -0.3 | 0.82 | 1.84 | 1.10 |
EPS (Diluted) | 0.26 | -2.21 | -1.64 | -0.39 | -2.88 | 4.75 | 1.03 | -0.74 | 0.13 | 2.33 | -0.86 | 0.02 | -0.05 | -0.91 | -0.3 | 0.80 | 1.79 | 1.05 |
EBITDA | 9.72M | -40.54M | -29.69M | 3.4M | -55.27M | 122.35M | 26.15M | -3.53M | 12.96M | 14.21M | 34.45M | 25.85M | 12.89M | 15.78M | 10.39M | 24.52M | 23.93M | 17.81M |
EBIT | 9.72M | -49.31M | -38.32M | -5.6M | -64.12M | 113.59M | 17.23M | -12.14M | 3.46M | 14.21M | 24.38M | 12.69M | 9.1M | -8.36M | 37.69M | 11.91M | 11.64M | 4.71M |
Depreciation & Amortization | n/a | 8.77M | 8.63M | 8.99M | 8.85M | 8.77M | 8.92M | 8.61M | 9.51M | 9.57M | 10.07M | 13.51M | 13.09M | 13.64M | 12.95M | 12.61M | 12.29M | 13.09M |